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INTRODUCTION
 Acne is one of the commonest dermatological 
disorders with a prevalence of 22%1 It is a disease 
of the pilosebaceous follicle with presence in 
70-95% of dermatological patients.2 Endocrine 
mechanisms control the components of sebocyte 
function—namely lipid synthesis, proliferation and 
differentiation.3 Androgens upregulate sebaceous 
gland function by binding to the nuclear androgen 
receptors (ARs). Highest density of these has been 
demonstrated in sebaceous glands.
 Testosterone (T) and dihydrotestosterone (DHT) 
are synthesized in the skin and bind to the androgen 
receptor.4 Clinical studies support the role of 
androgenic hormones in acne pathogenesis and 
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Abstract
Objectives: To correlate acne severity with elevated androgen levels and to compare androgen levels 
between cases and controls.
Methods: This case-control study was carried out in the Department of Dermatology, Mayo Hospital, 
Lahore from March 2016 – March 2017.  Two hundred and seventy patients and eighty age and gender-
matched controls were recruited after ethical approval and informed consent and categorized into mild, 
moderate and severe acne. Severity was correlated with serum Testosterone, Dihydrotestoststerone and 
Dihydroepiandrosterone Sulphate levels. Quantitative variables were expressed as median and percentiles, 
comparisons done by Mann-Whitney and correlations by Spearman correlation. P-value of <0.05 was 
considered statistically significant. 
Results: There were 142 (41%) males and 208 (59%) females. Ninety-Seven patients had mild, 108 
moderate and 65 had severe disease. Median hormonal levels were 3.5ng/ml, 184pg/ml and 0.82ug/dl 
for Testosterone, Dihydrotestosterone and Dihydroepiandrosterone Sulphate respectively which differed 
significantly between cases and controls. There was no correlation with severity but the levels differed 
significantly between the different grades in case of Testosterone and DHEAS.
Conclusion: Androgens are not directly correlated with acne severity, but affect acne severity as seen in 
difference between their levels in different grades of acne. Anti-androgens may be initiated early in acne 
resistant to conventional therapy.
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cite the approximation of acne onset with surge of 
dihydroepiandrosterone sulphate (DHEA-S), acne 
in congenital adrenal hyperplasia (CAH), sudden 
onset acne, androgens administration leading 
to acne and improvement by androgen receptor 
blockers.
 DHEA-S was found to be in the highest 
concentration in both sexes, which is converted 
by sebocytes and dermal papilla into testosterone 
and DHT. Androgen receptor (AR) malfunction 
is associated with acne.5 Patients with androgen 
excess, like Cushing’s syndrome, Polycystic 
Ovaries (PCOs) and CAH, can all have acne.
However, there are conflicting studies regarding 
androgen levels in acne severity. A positive 
relationship was not found between grades of acne 
severity and hyperandrogenism.6 In some, raised 
DHEA-S levels were found.7 Androgens exhibit 
increased receptor sensitivity and 5α-reductase 
activity leading to high DHT levels.8
 Acne may be associated with endocrinopathies, 
PCOs and ovarian tumours, if associated with 
hyperandrogenism. It is important to standardize 
the hormonal profile and control relapses in 
breakouts of acne. Treatment includes androgen 
receptor blocker, lowering androgen production by 
adrenals and ovaries.9
 The objectives of this study were to correlate 
acne severity with elevated androgen levels and 
to compare androgen levels between cases and 
controls.
METHODS
 Two hundred and seventy acne patients and 
eighty age and gender matched controls presenting 
to the outpatient department of Mayo Hospital, 
Lahore were included. Patients were studied 
for hyperandrogenism. Patients having features 
of hyperandrogenism clinically (e.g. hirsutism) 
were excluded as well as those patients having a 
known cause of hyperandrogenism like PCOS or 
oral contraceptives in case of females or Cushing’s 
syndrome (as tested on Ultrasonography and 
fasting serum cortisol levels). Patients presenting 
for the first time were selected. After approval 
from the ethical committee and informed consent, 
after ruling out polycystic ovaries on ultrasound 
and after basal serum cortisol, fasting androgen 
levels were recorded. Levels were measured by 
ELISA using kits by Diasource Belgium and tests 
performed on Diamate 310. Levels of androgens 
were compared between cases and controls and 
correlated with acne severity. All data was entered 
into SPSS 20. Since the distribution was non-
normal, quantitative data was expressed in median 
and percentiles. Non-parametric tests like Mann-
Whitney were done for comparison between two 
groups. Correlation was measured by Spearman 
Correlation. A P value of <0.05 was considered 
statistically significant. 
RESULTS
 There were 142 (40.5%) males and 208 (59.4%) 
females. In cases, there were 155 (57%) females and 
115 (43%) males, whereas in controls, there were 54 
(67%) females and 26 (33%) males. In both males 
and females, the median age was 20 years. Median 
age of cases was 20 years and median age of controls 
was 21 years. Ninety-Seven (36%) of patients had 
mild disease, 108 (40%) had moderate disease and 
65 (24%) had severe disease.
 In the comparison of hormonal levels between 
cases and controls, there was  a statistically 
significant difference (Table-I) tested by Mann-
Whitney Test.
 In the correlation of serum levels of hormones 
with severity, there was no significant correlation 
(Table-II).
 In the comparison of hormonal levels between 
different grades of severity, there was a significant 
difference in case of Testosterone and DHEAS 
Table-I: Comparison of Androgenic Hormones between Cases and Controls.
Hormones   N Median IR P
Testosterone (ng/ml) Case 270 0.82 (0.56,5.77) <0.001
 Control 80 0.45 (0.36,4.99) 
DHT (pg/ml) Case 270 350.24 (280,545.7) <0.001
 Control 80 280 (215,375.45) 
DHEAS (µg/dl) Case 270 1.84 (1.27,2.55) <0.001
 Control 80 0.72 (0.52,2.42)
N= Number of Patients, SD= Standard Deviation, IR = Interquartile Range, P = Significance.
DHT = Dihydrotestosterone, DHEAS = Dihydroepiandrosterone Sulphate.
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(Table-III). Although there is a statistically 
significant difference in the values of hormones, 
there is no proportional correlation with severity 
(Table-II).
DISCUSSION
 In this study, the median age was 20 years. In 
the study by Kiyani et al.,10 the mean age was 
21.48 ± 4.73 years. In the study by Rahaman et al in 
India,11 the mean age of patients was 19.83 years, 
similar to this study. In the study by Saleh et al.12 
the mean age was 21.17 ± 4.21 years, also similar 
to this study. This coincides with the sebaceous 
activity at this age group under influence of 
androgens.4 
 Thirty six percent patients had mild, 40% 
moderate and 24% had severe disease. The highest 
proportion comprised of patients with mild disease. 
This is similar to the study by Kaiyani et al.10 This 
can be attributed to the inclusion criteria of selecting 
cases presenting for the first time.
 The levels of androgenic hormones are given in 
Table-I. In the study by Da Cunha et al.,13 54% of 
the patients had hyperandrogenism and DHEAS 
levels were most frequently elevated. In the study 
by Borgia et al.,14 there was elevation of at least one 
androgen.
 Marynick SP et al.15 in their study found that 
affected patients had increased testosterone and 
DHEA-S levels. In the study by Slayden M et al.,16 
acne was related to hyperandrogenism irrespective 
of the age of presentation. Sixty-three percent of 
patients had at least one androgen level above 95% 
of normal. The levels of Total T were elevated in 
38% of patients in 12-18 years of age and 5% in 
the 19 - 43 years age group, DHEAS levels were 
elevated  (>7.6 µmol/L) in 75% cases in 12-18 years 
and in 36% in 19 -43 year age group . In the study by 
Uysal et al.8, 55% of women with acne had elevation 
of at least one androgen.
 In this study, there was a significant difference 
in androgen levels between cases and controls 
(Table-I). In another study,17 there was no difference 
between cases and controls in case of Total 
Testosterone, Free Testosterone and DHT except 
DHEAS (P value <0.05). In the study by Vexaiu et 
al.,18 there was  a significant difference in levels of 
androgenic hormones between cases and controls, 
namely Testosterone 0.5 ng/ml versus 0.35 ng/
ml, Andostenedione 2.2 ng/dl versus 1.3 ng/dl, 
DHEAS 3.5 µg/dl versus 2.5 µg/dl in cases and 
controls respectively. In the study in Bangladesh,19 
10% acne patients had testosterone above normal 
levels.
 There was no significant correlation of androgens 
with severity (Table-II) with Spearman Correlation. 
In the study by Kaiyani et al.,10 no statistically 
significant relationship was demonstrated between 
testosterone levels and acne severity. In the study 
in Iran by Zandi S et al.,20 comparison of hormones 
Serum levels of androgens in acne 
Table-II: Correlation between Levels of 
Hormones & Severity (Spearman Correlation).
Correlation N r P
Testosterone VS Severity 270 0.077 0.205
DHT VS Severity 270 0.085 0.165
DHEAS VS Severity 270 0.104 0.088
**. Correlation is significant at 0.01 level (2 tailed)
N= Number of Patients, 
SD= Standard Deviation, 
P = Significance,
DHT = Dihydrotestosterone, 
DHEAS = Dihydroepiandrosterone Sulphate,
P = Significance, r = Correlation Co-efficient.
Table-III: Comparison of Level of Androgenic Hormones between different grades of Severity.
Since the data is non-parametric, median values are considered and mean/SD are obliterated.
 Severity N Median IR x2 P
Testosterone (ng/ml) Mild 97 0.65 (0.51,5.2) 14.04 0.001
 Moderate 108 1.4 (245.57,370.27)  
 Severe 65 2.48 (238.75,413.50)  
DHT (pg/ml) Mild 97 404.97 (271.45,493.80) 2.99 0.223
 Moderate 108 367 (283,600.50)  
 Severe 65 359 (289,534.6)  
DHEAS (µg/ml) Mild 97 1.7 (1.20,2.40) 6.37 0.041
 Moderate 108 1.98 (1.39,2.69)  
 Severe 65 1.8 (1.40,2.43)
N= Number of Patients, SD= Standard Deviation, IR = Interquartile Range, P = Significance.
DHT = Dihydrotestosterone, DHEAS = Dihydroepiandrosterone Sulphate, P = Significance.
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between patients having PCOS and non-PCOs, 
levels of testosterone and dihydroepiandrosterone 
were not statistically significant. In the study by 
Aizawa et al.,17 there was no correlation between 
androgen levels and severity. 
 Adityan B et al.21 in their study found that 
there was no association between acne severity 
and hyperandrogenism. In the study by Borgia 
et al.,14 although hyperandrogenemia was 
present, no correlation was found with severity. 
In the study by Henze et al.,22 more than 30% 
of patients had elevated testosterone or DHEAS 
levels. However, large numbers with severe 
acne had normal androgens. This could be 
attributed to the fact that neither testosterone, 
nor DHEAS have strong androgenic potential 
in the pilosebaceous unit. Rather local enzymes 
are responsible for reduction of testosterone 
to 5α-dihydrotestosterone. Severe virilization 
could be caused by the overactivity of either 5-α 
reductase22 or androgen receptor. 
 In this study, comparison of androgens between 
the three grades of acne revealed significant 
difference in Testosterone and DHEAS levels 
(Table-III), but not in DHT. In the study by Cibula 
et al.,6 no positive correlation was found between 
acne severity and clinical/ laboratory values of 
androgenism. Women with increased severity 
had lower free testosterone. Contrary to this, in 
the study by Saleh et al.,12 levels of testosterone, 
dihydroepiandrosterone and androstenedione were 
significantly raised in severe acne as compared to 
moderate (p = <0.005) and mild acne (p = 0.001). 
 Lucky AW et al.23 in their study found that females 
with severe comedonal acne had significantly higher 
DHEA-S and testosterone levels. In the study by 
Seraifi et al.,24 only DHEA-S was raised in women 
with acne but not hyperandrogenism, similar to 
this study.  Similarly, in India25  although higher 
testosterone levels were found in cases compared 
to controls, statistically significant difference 
was observed in moderate and severe acne only. 
Thus, the role of androgens in acne pathogenesis 
can be observed by the difference in their serum 
levels, especially in the case of Testosterone and 
DHEAS.25
CONCLUSION
 Although androgenic hormones may be raised 
in the acne patients as compared to controls, only 
Testosterone and DHEA-S levels serve as markers 
of acne severity. Any therapy targeted towards acne 
and its severity can, therefore, be directed towards 
the ovarian androgen production, or blocking 
of androgen receptors in the pilosebaceous unit. 
Thus hormonal therapy can be an adjuvant to early 
treatment in acne.
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